This aim of the present study was to evaluate the effects of dietary xylooligosaccharides (XOS) on the intestinal morphology, nitrogen metabolism, faecal ammonia release, antioxidant capacity, and immune organ indices of broilers fed corn-soybean meal diet. A total of 240 healthy 1-day-old Arbour Acres (AA) broilers were randomly divided into four treatment groups receiving XOS supplementation of 0 (Control), 150, 300, and 450 mg/kg to basal diet for 6 weeks. Six replicates with 10 birds each were prepared for each treatment. Results showed that the villus height of duodenum, jejunum, and ileum and the villus height to crypt depth ratio of jejunum were increased significantly in the broilers receiving 150 mg/kg XOS compared with those in the Control (p < 0.05). Nitrogen utilisation from day 19 to 21 was higher in the 150 mg/kg XOS group than in the Control (p < 0.05). Moreover, the addition of 150 mg/kg XOS reduced the nitrogen excretion from day 40 to 42 (p < 0.05), and all XOS treatments increased the nitrogen utilisation from day 40 to 42 (p < 0.05). All dietary XOS supplementations decreased the faecal ammonia concentration on day 21 (p < 0.05), and the addition of 150 and 450 mg/kg XOS induced a lower faecal ammonia concentration compared with that of the Control on day 42 (p < 0.05). Dietary supplementation of 300 and 450 mg/kg XOS enhanced the activity of serum total antioxidant capacity compared with that in the Control and 150 mg/kg XOS groups at the age of 42 days (p < 0.05). Supplementation with 450 mg/kg XOS significantly increased the index of thymus (p < 0.05) and the content of total protein compared with those of the Control at the age of 21 days (p < 0.05). Therefore, dietary supplementation with 150 mg/kg XOS have a beneficial effect on broilers.
A total of 240 1-day-old Arbor Acres broiler chickens were randomly distributed to 4 treatment groups with 6 replicates and 10 birds per replicate. Chickens were fed with corn-soybean meal diet supplementation with additions of 0, 150, 300, and 450 mg/kg XOS for 42 days. At 4 weeks of age, the average feeding time was reduced in the 450 mg/kg XOS group (p < 0.05), and the percentage of feeding time was increased in the 300 mg/kg XOS group (p < 0.05). At 5 weeks of age, broilers fed with 300 mg/kg XOS had increased the percentage of feeding time (p < 0.05), and 450 mg/kg XOS had increased the feeding frequency and percentage of feeding time (p < 0.05). At 6 weeks of age, the feeding frequency was highest in the 450 mg/kg XOS group (p < 0.05). During 4 to 6 weeks of age, the average feeding time was increased in 300 mg/kg XOS group (p < 0.05), the frequency was improved in the 450 mg/kg XOS group (p < 0.05), and the percentage of feeding time was longer in the XOS group than that in the control group (p < 0.05). The average daily gain was improved during days 22–42 and days 1–42 in the 150 mg/kg XOS group (p < 0.05). Broilers fed with 300 mg/kg XOS had an increased eviscerated rate (p < 0.05). The pH45min of breast muscle was highest in the 450 mg/kg XOS group (p < 0.05), as well as the pH45min and pH24h of thigh muscle, which improved in the 300 mg/kg and 450 mg/kg XOS groups (p < 0.05). In addition, the cooking loss of thigh muscle was reduced in the 300 mg/kg XOS group (p < 0.05). In conclusion, dietary supplementation with XOS had positive effects on the feeding behavior, growth performance, and meat quality of broiler chickens.
Fructus Ligustri Lucidi (FLL) is a traditional tonic Chinese medicine with a long history of application due to its various pharmacological effects, but there are fewer studies on the use of FLL to alleviate fatty liver in animals. The objective of the current study was to assess the influence of FLL fermentation products on fatty liver hemorrhagic syndrome in hens during the late stages of egg production. The study involved 288 Hy-Line Brown laying hens, aged 500 days, which were randomly allocated into 4 groups, with each group having 6 replicates of 12 chickens. Hens were fed a basal diet (control group, group Ι), a high-energy diet (model group, group II) and a high-energy diet supplemented with 0.05% and 0.1% FLL fermentation product (groups III and IV). The duration of the pre-experiment was 1 week, and the trial period was 12 weeks. The results showed that the addition of FLL fermentation product to high-energy diets significantly increased egg weight and reduced eggshell breakage rate. High-energy diet supplementation with FLL fermentation product increased serum T-AOC and T-SOD activity (p < 0.05), and reduced serum MDA content (p < 0.05). As more FLL fermentation product was added, there was a notable reduction in lipid droplets in liver tissues, alleviation of symptoms of steatosis, and suppression of mRNA expression levels of lipid synthesis genes ACC, FAS, and SCD in the liver (p < 0.001). Transcription factors such as NR1H3 (p < 0.01), LPK (p < 0.001), and SREBF1 (p < 0.05) were differentially down-regulated, significantly reducing MTTP gene expression (p < 0.001). It can be concluded that the addition of 0.1% FLL fermentation product can enhance the productivity of laying hens during their late laying phase, increase the antioxidant capacity, inhibit the mRNA expression level of genes related to fat synthesis in the liver, reduce the accumulation of fat, and alleviate the fatty liver of laying hens caused by the high-energy diet.